Welcome Nurses!

Valeant Pharmaceuticals North America, makers of DIASTAT® AcuDial™ (diazepam rectal gel) is proud to support you as you assist the patients in your care. We believe you are the heroes helping your patients and students to greater mobility and greater peace of mind by encouraging seizure planning and preparation.
When a Seizure Strikes, Are Your Patients Prepared?

Preparation is critical1 as more than 30% of seizures are not controlled by AEDs alone2. A complete Seizure Preparedness Plan can help your patients live life with less fear and uncertainty. Learn how to create a plan.

A Complete Epilepsy Plan Has All the Pieces

DIASTAT AcuDial is the first and only FDA-approved, acute at-home treatment for patients two years and older on stable anti-epileptic medications (AEDs) who experience bouts of increased seizure activity. Learn more about DIASTAT AcuDial.

New! Nurses' Resource Center

Stay Informed- Sign up for Seizure Planning News Today!

References:
  1. Pellock JM,Marmarou A,DeLorenzo R.Time to treatment in prolonged seizure episodes. Epilepsy & Behav.2004;5:192-196.
  2. DeGiorgio CM,Heck CN,Rabinowicz AL,Gott PS,Smith T,Correale J.Serum neuron-specific enolase in the major subtypes of status epilepticus.Neurology.1999;52:746-749.

 
IMPORTANT SAFETY INFORMATION

DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.

In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.